APLS
Apellis Pharmaceuticals Inc
3.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +81.0% | +1,908.2% | -95.0% | +1,908.2% | +148.7% | +44.1% | +73.7% | -0.3% | +20.0% | +0.7% | -13.3% | |
| – | -17.2% | +97.7% | +402.2% | +42.7% | +173.4% | +114.6% | +55.7% | +28.9% | +16.3% | +7.7% | -8.9% | |
| – | +3,996.0% | -96.0% | +402.2% | +42.7% | +389.3% | +292.8% | +84.6% | -44.5% | – | – | – | |
| – | +259.0% | -93.2% | -2,888.0% | – | – | -63.3% | -577.5% | – | – | – | – | |
| – | -100.0% | – | 0.0% | +0.0% | 0.0% | +220.3% | -79.7% | +38.2% | -49.3% | -47.9% | -22.3% | |
| – | – | – | 0.0% | +0.0% | +0.0% | +18,623.5% | – | -75.8% | -101.1% | -40.2% | -22.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,404,051.8% | -64.0% | +1,050.6% | -22.9% | -14.6% | -98.6% | -213.5% | – | -360.5% | – | – | |
| – | +0.0% | +0.0% | +0.0% | +598.7% | +0.0% | +75.3% | -100.0% | – | – | – | -100.0% | |
| – | +119.0% | -64.0% | +1,228.0% | -33.2% | +194.6% | +78.1% | -43.3% | -6.8% | +7.9% | -62.2% | -94.0% | |
| – | +152.5% | -149.8% | – | -99.6% | +28,053.6% | +22.4% | -65.3% | -218.7% | – | – | -8.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.